ARCHIVES

Cancer Act Renewals Marked By Disputes Over NCI Authorities

This article is from The Cancer Letter archive.

Vol. 16 No. 38 | October 5, 1990

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Concepts For Education Initiatives In Breast Ca Approved As RFA

July 9, 1993